4.3 Review

Personalized oncology: genomic screening in phase 1

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

Dabrafenib and Trametinib, Alone and in Combination for BRAF-Mutant Metastatic Melanoma

Alexander M. Menzies et al.

CLINICAL CANCER RESEARCH (2014)

Article Oncology

Liquid Biopsies: Genotyping Circulating Tumor DNA

Luis A. Diaz et al.

JOURNAL OF CLINICAL ONCOLOGY (2014)

Article Genetics & Heredity

Traditional Roles in a Non-Traditional Setting: Genetic Counseling in Precision Oncology

Jessica N. Everett et al.

JOURNAL OF GENETIC COUNSELING (2014)

Letter Medicine, General & Internal

Ceritinib in ALK-Rearranged Non-Small-Cell Lung Cancer REPLY

Alice T. Shaw et al.

NEW ENGLAND JOURNAL OF MEDICINE (2014)

Article Medicine, General & Internal

Ceritinib in ALK-Rearranged Non-Small-Cell Lung Cancer

Alice T. Shaw et al.

NEW ENGLAND JOURNAL OF MEDICINE (2014)

Review Oncology

Real-time Liquid Biopsy in Cancer Patients: Fact or Fiction?

Klaus Pantel et al.

CANCER RESEARCH (2013)

Review Oncology

Genomic Medicine Frontier in Human Solid Tumors: Prospects and Challenges

Rodrigo Dienstmann et al.

JOURNAL OF CLINICAL ONCOLOGY (2013)

Article Oncology

Emerging Paradigms in the Development of Resistance to Tyrosine Kinase Inhibitors in Lung Cancer

Justin F. Gainor et al.

JOURNAL OF CLINICAL ONCOLOGY (2013)

Article Genetics & Heredity

Activating ESR1 mutations in hormone-resistant metastatic breast cancer

Dan R. Robinson et al.

NATURE GENETICS (2013)

Article Medicine, General & Internal

Crizotinib versus Chemotherapy in Advanced ALK-Positive Lung Cancer

Alice T. Shaw et al.

NEW ENGLAND JOURNAL OF MEDICINE (2013)

Article Medicine, General & Internal

Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer

Sarah-Jane Dawson et al.

NEW ENGLAND JOURNAL OF MEDICINE (2013)

Review Multidisciplinary Sciences

Cancer Genome Landscapes

Bert Vogelstein et al.

SCIENCE (2013)

Review Biochemistry & Molecular Biology

The Genetic Basis for Cancer Treatment Decisions

Janet E. Dancey et al.

Article Oncology

Personalized Medicine in a Phase I Clinical Trials Program: The MD Anderson Cancer Center Initiative

Apostolia-Maria Tsimberidou et al.

CLINICAL CANCER RESEARCH (2012)

Article Multidisciplinary Sciences

Systematic identification of genomic markers of drug sensitivity in cancer cells

Mathew J. Garnett et al.

NATURE (2012)

Article Medicine, General & Internal

Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing

Marco Gerlinger et al.

NEW ENGLAND JOURNAL OF MEDICINE (2012)

Article Multidisciplinary Sciences

Genome Sequencing Identifies a Basis for Everolimus Sensitivity

Gopa Iyer et al.

SCIENCE (2012)

Article Cell Biology

Intratumor Heterogeneity: Seeing the Wood for the Trees

Timothy A. Yap et al.

SCIENCE TRANSLATIONAL MEDICINE (2012)

Review Oncology

Circumventing Cancer Drug Resistance in the Era of Personalized Medicine

Levi A. Garraway et al.

CANCER DISCOVERY (2012)

Review Biochemistry & Molecular Biology

Hallmarks of Cancer: The Next Generation

Douglas Hanahan et al.

Article Oncology

Reasons given by patients for participating, or not, in Phase 1 cancer trials

S. Catt et al.

EUROPEAN JOURNAL OF CANCER (2011)

Article Cell Biology

Personalized Oncology Through Integrative High-Throughput Sequencing: A Pilot Study

Sameek Roychowdhury et al.

SCIENCE TRANSLATIONAL MEDICINE (2011)

Article Cell Biology

Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR Inhibitors

Lecia V. Sequist et al.

SCIENCE TRANSLATIONAL MEDICINE (2011)

Review Cell Biology

Clinical outcomes in non-small-cell lung cancer patients with EGFR mutations: pooled analysis

Luis Paz-Ares et al.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2010)

Article Medicine, General & Internal

Gefitinib or Chemotherapy for Non-Small-Cell Lung Cancer with Mutated EGFR.

Makoto Maemondo et al.

NEW ENGLAND JOURNAL OF MEDICINE (2010)

Article Medicine, General & Internal

Anaplastic Lymphoma Kinase Inhibition in Non-Small-Cell Lung Cancer

Eunice L. Kwak et al.

NEW ENGLAND JOURNAL OF MEDICINE (2010)

Article Medicine, General & Internal

Inhibition of Mutated, Activated BRAF in Metastatic Melanoma

Keith T. Flaherty et al.

NEW ENGLAND JOURNAL OF MEDICINE (2010)

Article Oncology

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

E. A. Eisenhauer et al.

EUROPEAN JOURNAL OF CANCER (2009)

Review Multidisciplinary Sciences

The cancer genome

Michael R. Stratton et al.

NATURE (2009)

Review Hematology

Pathobiology of ALK+ anaplastic large-cell lymphoma

Hesham M. Amin et al.

Review Multidisciplinary Sciences

Melanoma biology and new targeted therapy

Vanessa Gray-Schopfer et al.

NATURE (2007)

Review Biochemistry & Molecular Biology

Cancer genes and the pathways they control

B Vogelstein et al.

NATURE MEDICINE (2004)

Article Multidisciplinary Sciences

Mutations of the BRAF gene in human cancer

H Davies et al.

NATURE (2002)

Article Medicine, General & Internal

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

DJ Slamon et al.

NEW ENGLAND JOURNAL OF MEDICINE (2001)